This blood test measures three Epstein-Barr virus antibodies to show whether you have ever been infected and whether an infection might be active now. It suits people investigating possible glandular fever or unexplained fatigue.
3 biomarkers as listed by Medichecks.
This test measures three markers: EBNA IgG antibodies, Epstein-Barr virus capsid antigen IgG and Epstein-Barr virus capsid antigen IgM. Together these distinguish a past infection from one that might be active now, because IgM antibodies tend to appear during or shortly after a current infection while the IgG markers reflect longer-term immunity. Epstein-Barr virus causes glandular fever, so this combination is useful for working out where you are in relation to an infection rather than simply confirming exposure.
Medichecks does not list a named comparison group for this test, but against the wider set of immunity tests we track, its three biomarkers put it in the upper range for this type of test, and its £109 price sits below the typical cost of similarly sized immunity tests.
The scorecard reflects this: it scores strongly for clinical depth given how many antibody markers are included for a test of this kind, and for value for money because the price undercuts the category norm. It also scores well for clarity and documentation, since the listing sets out the biomarkers, turnaround and collection options clearly, and for results and follow-up because a doctor reviews every result. It scores more moderately on collection convenience because it still requires a venous draw rather than a finger-prick sample.
This suits you if you want to understand your history with Epstein-Barr virus, for example investigating unexplained fatigue or confirming a possible past bout of glandular fever, or if you have current symptoms and want to see whether the IgM marker suggests a recent or ongoing infection. Medichecks does not list a peer test in our data for this specific antibody combination, so we cannot point you to a cheaper or deeper named alternative; based on the data we do have, its combination of a below-average price and an above-average marker count for this type of test make it a reasonable starting point if antibody status, rather than direct viral DNA, is what you need.
You can have this done at an in-store clinic, through a home nurse visit, or with a venous blood draw at a clinic; Medichecks does not offer an at-home finger-prick option for this test. Results are typically ready within 5 days, and every result is reviewed by a doctor before you receive it.
Three Epstein-Barr virus antibodies are checked here to tell whether you have had a past infection and whether one could be active now. At £109 it comes in about 16% below the £130.25 median for similarly sized immunity tests we track, and its three markers put it well ahead on depth for a test of this kind. The main catch is that it still needs a venous blood draw rather than a simple finger-prick.
The listing publishes a short description, the full biomarker list, a stated turnaround, clear collection options, the sample type; it does not state what the report looks like.
3 biomarkers, placing it in the 83rd percentile of immunity tests we track.
A blood sample taken at home by a visiting nurse or phlebotomist; with a venous or clinic option as well; a home nurse visit is offered; results in around 5 days, slower than similar tests.
Results are reviewed by a doctor; the provider does not describe the report format.
Trustpilot 4.5 from 2,477 reviews; accredited lab (UKAS ISO 15189 partner labs); doctor review as standard; trading 25+ years.
£109.00 against a median of £130.25 for the 93 similarly sized immunity tests we track (-16%).
Calculated 13 September 2026 from the facts we hold about this test and provider, using our published scoring formula. Scores are not hand-edited.
Highly rated for depth and priced well below the market
An 8-marker blood test covering white and red blood cells, vitamin D, B12, iron status and inflammation, for a broad check of immune-related health.
Six-marker immunity panel below the category median
A six-marker blood panel covering IgG, IgM and IgA antibodies plus total protein, albumin and globulin, for anyone investigating frequent infections or possible immune deficiency.
Combined Covid tests, discontinued from 30 Sept 2026
A combined blood test measuring both nucleocapsid antibodies, which indicate past infection, and spike protein antibodies, which indicate a vaccine or infection response.
Broad 13-marker urine panel, competitively priced
A urine analysis under the microscope plus a culture to check for bacteria, covering signs of infection, kidney health and metabolic changes. Suits monitoring urinary symptoms or investigating an abnormal result.
